AAAAAA

   
Results: 1-7 |
Results: 7
AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-FACTOR XA AND ANTI-THROMBIN ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN)
Authors: MISMETTI P LAPORTESIMITSIDIS S NAVARRO C SIE P DAZEMAR P NECCIARI J DURET JP GAUD C DECOUSUS H BONEU B
Citation: P. Mismetti et al., AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-FACTOR XA AND ANTI-THROMBIN ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN), Thrombosis and haemostasis, 79(6), 1998, pp. 1162-1165
PHARMACODYNAMICS AND TOLERANCE OF 2 NADROPARIN FORMULATIONS (10,250 AND 20,500 ANTI XA IU-ML(-1)) DELIVERED FOR 10 DAYS AT THERAPEUTIC DOSE
Authors: BONEU B NAVARRO C CAMBUS JP CAPLAIN H DAZEMAR P NECCIARI J DURET JP GAUD C SIE P
Citation: B. Boneu et al., PHARMACODYNAMICS AND TOLERANCE OF 2 NADROPARIN FORMULATIONS (10,250 AND 20,500 ANTI XA IU-ML(-1)) DELIVERED FOR 10 DAYS AT THERAPEUTIC DOSE, Thrombosis and haemostasis, 79(2), 1998, pp. 338-341
AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-XA AND ANTI-IIA ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN)
Authors: BONEU B MISMETTI P LAPORTE S NAVARRO C SIE P DAZEMAR P NECCIARI J DURET JP GAUD C DECOUSUS H
Citation: B. Boneu et al., AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-XA AND ANTI-IIA ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN), Thrombosis and haemostasis, 1997, pp. 1149-1149
COMPARISON OF THE BIOAVAILABILITY OF 2 NADROPARIN FORMULATIONS (10000AND 20000 ANTI-XA IU.ML-1) IN HEALTHY-YOUNG VOLUNTEERS
Authors: BONEU B NAVARRO C CAMBUS JP CAPLAIN H DAZEMAR P NECCIARI J DURET JP GAUD C SIE P
Citation: B. Boneu et al., COMPARISON OF THE BIOAVAILABILITY OF 2 NADROPARIN FORMULATIONS (10000AND 20000 ANTI-XA IU.ML-1) IN HEALTHY-YOUNG VOLUNTEERS, Thrombosis and haemostasis, 1997, pp. 1160-1160
EFFECTS OF TILUDRONATE ON BONE LOSS IN PARAPLEGIC PATIENTS
Authors: CHAPPARD D MINAIRE P PRIVAT C BERARD E MENDOZASARMIENTO J TOURNEBISE H BASLE MF AUDRAN M REBEL A PICOT A GAUD C
Citation: D. Chappard et al., EFFECTS OF TILUDRONATE ON BONE LOSS IN PARAPLEGIC PATIENTS, Journal of bone and mineral research, 10(1), 1995, pp. 112-118
BONE-MARROW TRANSPLANTATION IN 63 ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA IN FIRST COMPLETE REMISSION
Authors: VEY N BLAISE D STOPPA AM BOUABDALLAH R LAFAGE M SAINTY D COWEN D VIENS P LEPEU G BLANC AP JAUBERT D GAUD C MANNONI P CAMERLO J RESBEUT M GASTAUT JA MARANINCHI D
Citation: N. Vey et al., BONE-MARROW TRANSPLANTATION IN 63 ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA IN FIRST COMPLETE REMISSION, Bone marrow transplantation, 14(3), 1994, pp. 383-388
REGULATION OF ACETYLCHOLINE-RECEPTOR ALPHA-SUBUNIT VARIANTS IN HUMAN MYASTHENIA-GRAVIS - QUANTIFICATION OF STEADY-STATE LEVELS OF MESSENGER-RNA IN MUSCLE BIOPSY USING THE POLYMERASE CHAIN-REACTION
Authors: GUYON T LEVASSEUR P TRUFFAULT F COTTIN C GAUD C BERRIHAKNIN S
Citation: T. Guyon et al., REGULATION OF ACETYLCHOLINE-RECEPTOR ALPHA-SUBUNIT VARIANTS IN HUMAN MYASTHENIA-GRAVIS - QUANTIFICATION OF STEADY-STATE LEVELS OF MESSENGER-RNA IN MUSCLE BIOPSY USING THE POLYMERASE CHAIN-REACTION, The Journal of clinical investigation, 94(1), 1994, pp. 16-24
Risultati: 1-7 |